{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T06:22:06Z","timestamp":1788070926451,"version":"build-2784847793"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T00:00:00Z","timestamp":1693353600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Reproductive Immunology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.jri.2023.104141","type":"journal-article","created":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T11:18:34Z","timestamp":1693567114000},"page":"104141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Cost-effectiveness analysis of a first-trimester screening test for preterm preeclampsia in the Netherlands"],"prefix":"10.1016","volume":"160","author":[{"given":"Rik H.J.","family":"Beernink","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sicco A.","family":"Scherjon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas I.F.H.","family":"Cremers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoinette D.I.","family":"van Asselt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jri.2023.104141_bib1","doi-asserted-by":"crossref","first-page":"i1753","DOI":"10.1136\/bmj.i1753","article-title":"Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies","volume":"353","author":"Bartsch","year":"2016","journal-title":"Bmj"},{"key":"10.1016\/j.jri.2023.104141_bib2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.earlhumdev.2016.09.007","article-title":"Preeclampsia; short and long-term consequences for mother and neonate","volume":"102","author":"Bokslag","year":"2016","journal-title":"Early Hum. Dev."},{"key":"10.1016\/j.jri.2023.104141_bib3","unstructured":"C.B.v.d.S.S Netherlands), Consumentenprijzen CBS; prijsindex. (Accessed 1\u201310-2022 2022)."},{"key":"10.1016\/j.jri.2023.104141_bib4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.preghy.2021.08.113","article-title":"Enhancing the value of the sFlt-1\/PlGF ratio for the prediction of preeclampsia: Cost analysis from the Belgian healthcare payers\u2019 perspective","volume":"26","author":"Chantraine","year":"2021","journal-title":"Pregnancy Hypertens."},{"issue":"1","key":"10.1016\/j.jri.2023.104141_bib5","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12884-016-1195-2","article-title":"Perspectives, preferences and needs regarding early prediction of preeclampsia in Dutch pregnant women: a qualitative study","volume":"17","author":"Crombag","year":"2017","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.jri.2023.104141_bib6","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ejogrb.2014.04.033","article-title":"Care-as-usual provided to formerly preeclamptic women in the Netherlands in the next pregnancy: health care consumption, costs and maternal and child outcome","volume":"179","author":"Delahaije","year":"2014","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"2","key":"10.1016\/j.jri.2023.104141_bib7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1046\/j.1365-3016.2000.00251.x","article-title":"The Dutch 'Folic Acid Campaign'--have the goals been achieved?","volume":"14","author":"van der Pal-de Bruin","year":"2000","journal-title":"Paediatr. Perinat. Epidemiol."},{"key":"10.1016\/j.jri.2023.104141_bib8","unstructured":"S.Y. van der Ploeg CPB, Oomen P., Vos K., Prenatale Screening Infectieziekten en Erytrocytenimmunisatie (PSIE), in: TNO\/RIVM (Ed.) Procesmonitor 2017, TNO\/RIVM, 2019."},{"key":"10.1016\/j.jri.2023.104141_bib9","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.preghy.2021.06.012","article-title":"Cost-utility of a first-trimester screening strategy versus the standard of care for nulliparous women to prevent pre-term pre-eclampsia in Belgium","volume":"25","author":"Dubon Garcia","year":"2021","journal-title":"Pregnancy Hypertens."},{"key":"10.1016\/j.jri.2023.104141_bib10","doi-asserted-by":"crossref","unstructured":"G.P. Guy, K. Leslie, D. Diaz Gomez, K. Forenc, E. Buck, A. Khalil, B. Thilaganathan, Implementation of routine first trimester combined screening for pre-eclampsia: a clinical effectiveness study, Bjog, 2020.","DOI":"10.1111\/1471-0528.16361"},{"key":"10.1016\/j.jri.2023.104141_bib11","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/1472-6963-9-211","article-title":"Cost analysis of the Dutch obstetric system: low-risk nulliparous women preferring home or short-stay hospital birth--a prospective non-randomised controlled study","volume":"9","author":"Hendrix","year":"2009","journal-title":"BMC Health Serv. Res"},{"issue":"5","key":"10.1016\/j.jri.2023.104141_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063546","article-title":"Maternal characteristics, mean arterial pressure and serum markers in early prediction of preeclampsia","volume":"8","author":"Kuc","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.jri.2023.104141_bib13","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.preghy.2021.09.008","article-title":"The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice","volume":"27","author":"Magee","year":"2022","journal-title":"Pregnancy Hypertens."},{"issue":"423","key":"10.1016\/j.jri.2023.104141_bib14","first-page":"635","article-title":"Factors affecting the use of folic acid supplements in pregnant women in Glasgow","volume":"47","author":"McGovern","year":"1997","journal-title":"Br. J. Gen. Pr."},{"issue":"6","key":"10.1016\/j.jri.2023.104141_bib15","doi-asserted-by":"crossref","DOI":"10.3310\/hta12060","article-title":"Methods of prediction and prevention of pre-eclampsia: systematic reviews of accuracy and effectiveness literature with economic modelling","volume":"12","author":"Meads","year":"2008","journal-title":"Health Technol. Assess."},{"issue":"1","key":"10.1016\/j.jri.2023.104141_bib16","article-title":"Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation","volume":"214","author":"O'Gorman","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"7","key":"10.1016\/j.jri.2023.104141_bib17","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2165\/00019053-200220070-00002","article-title":"Standardisation of costs: the Dutch Manual for Costing in economic evaluations","volume":"20","author":"Oostenbrink","year":"2002","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jri.2023.104141_bib18","unstructured":"Perined, Perinatale zorg in Nederland anno 2019: landelijke perinatala cijfers en duiding, Utrecht."},{"issue":"1","key":"10.1016\/j.jri.2023.104141_bib19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/FM9.0000000000000005","article-title":"Screening and prevention of preeclampsia","volume":"1","author":"Poon","year":"2019","journal-title":"Maternal-Fetal Med."},{"issue":"S1","key":"10.1016\/j.jri.2023.104141_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijgo.12802","article-title":"The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention","volume":"145","author":"Poon","year":"2019","journal-title":"Int. J. Gynecol. Obstet."},{"issue":"7","key":"10.1016\/j.jri.2023.104141_bib21","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1161\/CIRCRESAHA.118.313276","article-title":"Preeclampsia: pathophysiology, challenges, and perspectives","volume":"124","author":"Rana","year":"2019","journal-title":"Circ. Res"},{"issue":"5","key":"10.1016\/j.jri.2023.104141_bib22","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/uog.12421","article-title":"Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta-analysis","volume":"41","author":"Roberge","year":"2013","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.jri.2023.104141_bib23","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ajog.2016.09.076","article-title":"The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis","volume":"216","author":"Roberge","year":"2017","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.jri.2023.104141_bib24","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ajog.2017.11.561","article-title":"Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis","volume":"218","author":"Roberge","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.jri.2023.104141_bib25","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1186\/s12913-018-3406-1","article-title":"Economic assessment of the use of the sFlt-1\/PlGF ratio test to predict preeclampsia in Germany","volume":"18","author":"Schlembach","year":"2018","journal-title":"BMC Health Serv. Res"},{"issue":"1","key":"10.1016\/j.jri.2023.104141_bib26","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/pd.2871","article-title":"Economic assessment of screening for pre-eclampsia","volume":"32","author":"Shmueli","year":"2012","journal-title":"Prenat. Diagn."},{"issue":"6","key":"10.1016\/j.jri.2023.104141_bib27","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1097\/HJH.0b013e3282fcc36e","article-title":"Low socioeconomic status is a risk factor for preeclampsia: the Generation R Study","volume":"26","author":"Silva","year":"2008","journal-title":"J. Hypertens."},{"issue":"1","key":"10.1016\/j.jri.2023.104141_bib28","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/pd.4485","article-title":"Psychological impact of first-trimester prevention for preeclampsia on anxiety","volume":"35","author":"Simeone","year":"2015","journal-title":"Prenat. Diagn."},{"key":"10.1016\/j.jri.2023.104141_bib29","unstructured":"H. Stepan, A. Galindo, M. Hund, D. Schlembach, J. Sillman, D. Surbek, M. Vatish, Clinical utility of sFlt-1 and PlGF in screening, prediction, diagnosis and monitoring of pre-eclampsia and fetal growth restriction, Ultrasound in Obstetrics & Gynecology n\/a(n\/a)."},{"key":"10.1016\/j.jri.2023.104141_bib30","doi-asserted-by":"crossref","unstructured":"H. Stepan, A. Galindo, M. Hund, D. Schlembach, J. Sillman, D. Surbek, M. Vatish, Clinical utility of sFlt-1 and PlGF in screening, prediction, diagnosis and monitoring of pre-eclampsia and fetal growth restriction, Ultrasound Obstet Gynecol, 2022.","DOI":"10.1002\/uog.26032"},{"issue":"6","key":"10.1016\/j.jri.2023.104141_bib31","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/uog.19039","article-title":"Comparison of diagnostic accuracy of early screening for pre-eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPREE","volume":"51","author":"Tan","year":"2018","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/j.jri.2023.104141_bib32","unstructured":"A. Tran-Duy, Decision Analysis in R for health economic Evaluation (DARE): An interactive web application. (Accessed 12\u201312-2022)."},{"key":"10.1016\/j.jri.2023.104141_bib33","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.preghy.2021.12.003","article-title":"Clinical interpretation and implementation of the sFlt-1\/PlGF ratio in the prediction, diagnosis and management of preeclampsia","volume":"27","author":"Verlohren","year":"2022","journal-title":"Pregnancy Hypertens."},{"issue":"5","key":"10.1016\/j.jri.2023.104141_bib34","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00228-007-0446-6","article-title":"Ten years after the Dutch public health campaign on folic acid: the continuing challenge","volume":"64","author":"de Walle","year":"2008","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.jri.2023.104141_bib35","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000512335","article-title":"Performance of the FMF first-trimester preeclampsia-screening algorithm in a high-risk population in the Netherlands","volume":"48","author":"Zwertbroek","year":"2021","journal-title":"Fetal Diagn. Ther."}],"container-title":["Journal of Reproductive Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165037823003479?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165037823003479?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T04:34:11Z","timestamp":1759034051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165037823003479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":35,"alternative-id":["S0165037823003479"],"URL":"https:\/\/doi.org\/10.1016\/j.jri.2023.104141","relation":{},"ISSN":["0165-0378"],"issn-type":[{"value":"0165-0378","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-effectiveness analysis of a first-trimester screening test for preterm preeclampsia in the Netherlands","name":"articletitle","label":"Article Title"},{"value":"Journal of Reproductive Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jri.2023.104141","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104141"}}